A. Grant, M. Crane, A. Laupacis, A. Griffiths, D. Burnett, Amanda Hood, C. Kluthe, Muneet Maghera, Malcolm Mann, M. Mansi, Kate Murray, M. Trempe, A. Otley
{"title":"Engaging Patients and Caregivers in Research for Pediatric IBD: Top 10 Research Priorities.","authors":"A. Grant, M. Crane, A. Laupacis, A. Griffiths, D. Burnett, Amanda Hood, C. Kluthe, Muneet Maghera, Malcolm Mann, M. Mansi, Kate Murray, M. Trempe, A. Otley","doi":"10.1097/MPG.0000000000002396","DOIUrl":null,"url":null,"abstract":"INTRODUCTION\nIncluding individuals with lived experience in pediatric IBD is essential to establishing a research agenda that is mutually impactful to both those treating and those experiencing the disease.\n\n\nMETHODS\nUsing the James Lind Alliance approach to research priority setting, a 10-member steering committee comprised of current and former pediatric IBD patients, caregivers, and clinicians was formed. A national survey, disseminated across Canada, elicited uncertainties which were divided into unanswered and answered research questions. Subsequently a research prioritization survey was disseminated where respondents ranked their top 20 research uncertainties. A final prioritization meeting was held to agree upon the top 10 uncertainties.\n\n\nRESULTS\nFrom 1209 research questions submitted by 363 participants, the list was reduced to 105 indicative questions that were within scope and deemed unanswered in the literature. Via the national research prioritization survey, this list was further reduced. The top 10 uncertainties identified at the final research consensus meeting, with 21 participants from all stakeholder groups, included: \"What are the causes of IBD?\", \"Can IBD be prevented?\", \"What role does diet have in the management of pediatric IBD?\". Other questions concerned flare ups, biomarkers, optimal patient education, long-term effects of medication and early-diagnosis, role of psychological support, and optimal approach to diagnosis.\n\n\nCONCLUSION\nThis research adds a unique perspective by deriving a list of pediatric IBD research uncertainties important by patients and caregivers, as well as clinicians.","PeriodicalId":16725,"journal":{"name":"Journal of Pediatric Gastroenterology & Nutrition","volume":"46 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric Gastroenterology & Nutrition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/MPG.0000000000002396","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7
Abstract
INTRODUCTION
Including individuals with lived experience in pediatric IBD is essential to establishing a research agenda that is mutually impactful to both those treating and those experiencing the disease.
METHODS
Using the James Lind Alliance approach to research priority setting, a 10-member steering committee comprised of current and former pediatric IBD patients, caregivers, and clinicians was formed. A national survey, disseminated across Canada, elicited uncertainties which were divided into unanswered and answered research questions. Subsequently a research prioritization survey was disseminated where respondents ranked their top 20 research uncertainties. A final prioritization meeting was held to agree upon the top 10 uncertainties.
RESULTS
From 1209 research questions submitted by 363 participants, the list was reduced to 105 indicative questions that were within scope and deemed unanswered in the literature. Via the national research prioritization survey, this list was further reduced. The top 10 uncertainties identified at the final research consensus meeting, with 21 participants from all stakeholder groups, included: "What are the causes of IBD?", "Can IBD be prevented?", "What role does diet have in the management of pediatric IBD?". Other questions concerned flare ups, biomarkers, optimal patient education, long-term effects of medication and early-diagnosis, role of psychological support, and optimal approach to diagnosis.
CONCLUSION
This research adds a unique perspective by deriving a list of pediatric IBD research uncertainties important by patients and caregivers, as well as clinicians.